<?xml version="1.0" encoding="UTF-8"?>
<p id="p0015">The development of new medicine also demands many years of research that involve stages of reasonable planning, synthesis, structural characterization, formulation of prototypes, preclinical and clinical trials. Therefore, the literature highlights, as alternative treatments for COVID-19, the repurposing of drugs, which is fast and useful in emergencies such as the one experienced today. The repurposing of drugs means the use of broad-spectrum medicine for a new disease, once its metabolic characteristics, doses, potential efficacy and adverse effects are pre-established due to drug studies conducted for their approval.
 <xref rid="b0020" ref-type="bibr">4</xref>, 
 <xref rid="b0025" ref-type="bibr">5</xref>
</p>
